Status | Study |
Recruiting |
Study Name: Lanreotide In Polycystic Kidney Disease Study Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD Date: 2014-04-02 Interventions: Drug: Lanreotide 120 mg, subcu |
Withdrawn |
Study Name: Repository Study of Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2013-11-07 |
Completed |
Study Name: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-10-11 Interventions: Drug: Tolvaptan MR 50/80 mg ca |
Active, not recruiting |
Study Name: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-06-20 Interventions: Drug: Octreotide-LAR 40 mg eve |
Terminated |
Study Name: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2010-10-12 Interventions: Drug: Sirolimus Patients will |
Enrolling by invitation |
Study Name: Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-12-23 |
Completed |
Study Name: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-11-27 Interventions: Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening) |
Completed |
Study Name: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2009-02-09 Interventions: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years. |
Terminated |
Study Name: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney Date: 2008-11-25 Interventions: Drug: tripterygium wilfordii T |
Recruiting |
Study Name: Polycystic Kidney Disease Data Repository Condition: Polycystic Kidney Disease Date: 2008-11-14 |